Protein glycosylation and tumor microenvironment alterations driving cancer hallmarks

A Peixoto, M Relvas-Santos, R Azevedo… - Frontiers in …, 2019 - frontiersin.org
Decades of research have disclosed a plethora of alterations in protein glycosylation that
decisively impact in all stages of disease and ultimately contribute to more aggressive cell …

Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer

NM Akella, L Ciraku, MJ Reginato - BMC biology, 2019 - Springer
Altered metabolism and deregulated cellular energetics are now considered a hallmark of
all cancers. Glucose, glutamine, fatty acids, and amino acids are the primary drivers of tumor …

Application of lectin microarrays for biomarker discovery

K Dang, W Zhang, S Jiang, X Lin, A Qian - ChemistryOpen, 2020 - Wiley Online Library
Many proteins in living organisms are glycosylated. As their glycan patterns exhibit protein‐,
cell‐, and tissue‐specific heterogeneity, changes in the glycosylation levels could serve as …

ST6Gal1: Oncogenic signaling pathways and targets

S Gc, SL Bellis, AB Hjelmeland - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
The Golgi-sialyltransferase ST6Gal1 (βgalactosidase α2, 6 sialyltransferase 1), adds the
negatively charged sugar, sialic acid, to the terminal galactose of N-glycosylated proteins …

[HTML][HTML] Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT

L Jia, J Li, P Li, D Liu, J Li, J Shen, B Zhu, C Ma… - Theranostics, 2021 - ncbi.nlm.nih.gov
Rationale: Epithelial-mesenchymal transition (EMT) has been recognized as an important
step toward high invasion and metastasis of many cancers including hepatocellular …

[HTML][HTML] FUCA1: An Underexplored p53 Target Gene Linking Glycosylation and Cancer Progression

D Hu, N Kobayashi, R Ohki - Cancers, 2024 - mdpi.com
Simple Summary Cancer is a difficult-to-cure disease with high worldwide incidence and
mortality. Among the many changes observed in cancer cells and patient samples is altered …

Role of glycans in cancer cells undergoing epithelial–mesenchymal transition

X Li, X Wang, Z Tan, S Chen, F Guan - Frontiers in oncology, 2016 - frontiersin.org
The term “cancer” refers to a group of diseases involving abnormal cell growth with the
potential to invade or spread to other parts of the body. Epithelial–mesenchymal transition …

Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2013–2014

DJ Harvey - Mass Spectrometry Reviews, 2018 - Wiley Online Library
This review is the eighth update of the original article published in 1999 on the application of
Matrix‐assisted laser desorption/ionization mass spectrometry (MALDI) mass spectrometry …

Bladder cancer cells interaction with lectin-coated surfaces under static and flow conditions

R Szydlak, IH Øvreeide, M Luty, T Zieliński… - International Journal of …, 2023 - mdpi.com
Aberrant expression of glycans, ie, oligosaccharide moiety covalently attached to proteins or
lipids, is characteristic of various cancers, including urothelial ones. The binding of lectins to …

Altered glycosylation in progression and management of bladder cancer

M Wilczak, M Surman, M Przybyło - Molecules, 2023 - mdpi.com
Bladder cancer (BC) is the 10th most common malignancy worldwide, with an estimated
573,000 new cases and 213,000 deaths in 2020. Available therapeutic approaches are still …